FINLIUS
Live / Applied — Third extension granted (statement of use) (as of 26 Feb 2026)
What this means for you
Not registered yet, but its 20 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98277784
- Mark type
- Stylized text
- Filed
- 20 Nov 2023
- Published for opposition
- 30 Jul 2024
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of autoimmune diseases and disorders
Owner
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 27 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2026 — SOU EXTENSION 3 GRANTED
- 26 Feb 2026 — SOU EXTENSION 3 FILED
- 26 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Sept 2025 — SOU EXTENSION 2 GRANTED
- 05 Sept 2025 — SOU EXTENSION 2 FILED
- 05 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Dec 2024 — SOU EXTENSION 1 GRANTED
- 12 Dec 2024 — SOU EXTENSION 1 FILED
- 12 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 24 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jul 2024 — PUBLISHED FOR OPPOSITION